Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest Articlesp53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
Leukemia Research, 07/13/09
Sheth N et al. - The data indicates that p53 nuclear expression but not CD56 expression, along with increased proliferation index is associated with disease progression from intramedullary to extramedullary sites in MM.
Related Articles
Hyperlipidemic myeloma: review of 53 cases
Annals of Hematology, 11/25/09
Relevance Score: 70%
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry
Acta Haematologica, 11/04/09
Relevance Score: 69%
Characteristics of Orbital Multiple Myeloma: A Case Report and Literature Review
Survey of Ophthalmology, 10/23/09
Relevance Score: 69%
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
Journal of Clinical Oncology, 10/02/09
Relevance Score: 69%
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study
Annals of Hematology, 11/25/09
Relevance Score: 68%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal-type
Blood, 12/09/09
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
Blood, 12/09/09
TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway
Oncogene, 12/09/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
Blood, 12/09/09
Solitary Plasmacytoma
American Journal of Clinical Oncology, 12/08/09
Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/08/09
Sponsor
Article Search
Sponsor
Sponsor